Answer
Somapacitan stimulates skeletal growth in children with growth hormone deficiency through effects on bone growth plates (epiphyses), acting directly via growth hormone receptors and/or indirectly via IGF-I produced throughout the body, predominantly in the liver.
Sources for this answer
- Sogroya 10mg/1.5 mL solution for injection in pre-filled penNovo Nordisk Limited · emc · SmPC §5.1 Pharmacodynamic properties · Version 2Document updated
Sources checked